Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) Stock Competitors & Peer Comparison
See OACCU's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Shell Companies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for OACCU and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| OACCU | $10.86 | -1.27% | 259.7M | 39.52 | $0.27 | N/A |
| CCIV | $24.25 | +5.90% | 44.4B | N/A | N/A | N/A |
| PSACU | $17.08 | +0.35% | 12B | -108.79 | -$0.16 | N/A |
| RTPY | $9.91 | -0.30% | 11.6B | N/A | N/A | N/A |
| LVRAW | $0.04 | +0.00% | 11.5B | N/A | N/A | N/A |
| CMLFU | $13.00 | -4.55% | 10.3B | -1444.44 | -$0.01 | N/A |
| PSAC | $13.78 | -0.36% | 9.7B | N/A | N/A | N/A |
| GRSVU | $11.39 | +3.36% | 6.8B | N/A | N/A | N/A |
| APSG | $7.39 | -25.88% | 6.3B | 36.95 | $0.20 | N/A |
| RTP | $10.03 | -4.48% | 6.3B | N/A | N/A | N/A |
Stock Comparison
Lucid Group, Inc. (NYSE: CCIV)
OACCU vs CCIV Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, CCIV has a market cap of 44.4B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while CCIV trades at $24.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas CCIV's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to CCIV's ROE of -13.92%. Regarding short-term risk, OACCU is less volatile compared to CCIV. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check CCIV's competition here
Property Solutions Acquisition Corp. (NASDAQ: PSACU)
OACCU vs PSACU Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, PSACU has a market cap of 12B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while PSACU trades at $17.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas PSACU's P/E ratio is -108.79. In terms of profitability, OACCU's ROE is +0.03%, compared to PSACU's ROE of +118.85%. Regarding short-term risk, OACCU is less volatile compared to PSACU. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check PSACU's competition here
Reinvent Technology Partners Y (NASDAQ: RTPY)
OACCU vs RTPY Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, RTPY has a market cap of 11.6B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while RTPY trades at $9.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas RTPY's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to RTPY's ROE of -0.43%. Regarding short-term risk, OACCU is less volatile compared to RTPY. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check RTPY's competition here
Levere Holdings Corp. (NASDAQ: LVRAW)
OACCU vs LVRAW Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, LVRAW has a market cap of 11.5B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while LVRAW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas LVRAW's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to LVRAW's ROE of N/A. Regarding short-term risk, OACCU is less volatile compared to LVRAW. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check LVRAW's competition here
CM Life Sciences, Inc. (NASDAQ: CMLFU)
OACCU vs CMLFU Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, CMLFU has a market cap of 10.3B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while CMLFU trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas CMLFU's P/E ratio is -1444.44. In terms of profitability, OACCU's ROE is +0.03%, compared to CMLFU's ROE of -0.39%. Regarding short-term risk, OACCU is less volatile compared to CMLFU. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check CMLFU's competition here
Property Solutions Acquisition Corp. (NASDAQ: PSAC)
OACCU vs PSAC Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, PSAC has a market cap of 9.7B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while PSAC trades at $13.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas PSAC's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to PSAC's ROE of +118.85%. Regarding short-term risk, OACCU is less volatile compared to PSAC. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check PSAC's competition here
Gores Holdings V, Inc. (NASDAQ: GRSVU)
OACCU vs GRSVU Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, GRSVU has a market cap of 6.8B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while GRSVU trades at $11.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas GRSVU's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to GRSVU's ROE of +0.00%. Regarding short-term risk, OACCU is more volatile compared to GRSVU. This indicates higher risk in terms of short-term price fluctuations for OACCU.Check GRSVU's competition here
Apollo Strategic Growth Capital (NYSE: APSG)
OACCU vs APSG Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, APSG has a market cap of 6.3B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while APSG trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas APSG's P/E ratio is 36.95. In terms of profitability, OACCU's ROE is +0.03%, compared to APSG's ROE of +0.03%. Regarding short-term risk, OACCU is less volatile compared to APSG. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check APSG's competition here
Reinvent Technology Partners (NYSE: RTP)
OACCU vs RTP Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, RTP has a market cap of 6.3B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while RTP trades at $10.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas RTP's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to RTP's ROE of -0.58%. Regarding short-term risk, OACCU is less volatile compared to RTP. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check RTP's competition here
Dragoneer Growth Opportunities Corp. (NYSE: DGNR)
OACCU vs DGNR Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, DGNR has a market cap of 5.8B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while DGNR trades at $9.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas DGNR's P/E ratio is -308.67. In terms of profitability, OACCU's ROE is +0.03%, compared to DGNR's ROE of +0.02%. Regarding short-term risk, OACCU is less volatile compared to DGNR. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check DGNR's competition here
VectoIQ Acquisition Corp. II (NASDAQ: VTIQ)
OACCU vs VTIQ Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, VTIQ has a market cap of 5.6B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while VTIQ trades at $10.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas VTIQ's P/E ratio is 91.50. In terms of profitability, OACCU's ROE is +0.03%, compared to VTIQ's ROE of +472.81%. Regarding short-term risk, OACCU is more volatile compared to VTIQ. This indicates higher risk in terms of short-term price fluctuations for OACCU.Check VTIQ's competition here
VectoIQ Acquisition Corp. II (NASDAQ: VTIQU)
OACCU vs VTIQU Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, VTIQU has a market cap of 5.6B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while VTIQU trades at $10.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas VTIQU's P/E ratio is 100.60. In terms of profitability, OACCU's ROE is +0.03%, compared to VTIQU's ROE of +472.81%. Regarding short-term risk, OACCU is more volatile compared to VTIQU. This indicates higher risk in terms of short-term price fluctuations for OACCU.Check VTIQU's competition here
Vector Acquisition Corporation (NASDAQ: VACQ)
OACCU vs VACQ Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, VACQ has a market cap of 5.5B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while VACQ trades at $11.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas VACQ's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to VACQ's ROE of -0.08%. Regarding short-term risk, OACCU is less volatile compared to VACQ. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check VACQ's competition here
SVF Investment Corp. 3 (NASDAQ: SVFC)
OACCU vs SVFC Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, SVFC has a market cap of 5.1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while SVFC trades at $9.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas SVFC's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to SVFC's ROE of +0.05%. Regarding short-term risk, OACCU is less volatile compared to SVFC. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check SVFC's competition here
VG Acquisition Corp. (NYSE: VGAC)
OACCU vs VGAC Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, VGAC has a market cap of 5B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while VGAC trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas VGAC's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to VGAC's ROE of -1.21%. Regarding short-term risk, OACCU is less volatile compared to VGAC. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check VGAC's competition here
CM Life Sciences III Inc. (NASDAQ: CMLT)
OACCU vs CMLT Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, CMLT has a market cap of 4.2B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while CMLT trades at $8.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas CMLT's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to CMLT's ROE of N/A. Regarding short-term risk, OACCU is less volatile compared to CMLT. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check CMLT's competition here
Gores Holdings VI, Inc. (NASDAQ: GHVI)
OACCU vs GHVI Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, GHVI has a market cap of 4.2B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while GHVI trades at $14.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas GHVI's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to GHVI's ROE of -1.28%. Regarding short-term risk, OACCU is less volatile compared to GHVI. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check GHVI's competition here
Nextdoor Holdings, Inc. (NASDAQ: KVSB)
OACCU vs KVSB Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, KVSB has a market cap of 4.2B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while KVSB trades at $11.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas KVSB's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to KVSB's ROE of -0.07%. Regarding short-term risk, OACCU is less volatile compared to KVSB. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check KVSB's competition here
FTAC Olympus Acquisition Corp. (NASDAQ: FTOCU)
OACCU vs FTOCU Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, FTOCU has a market cap of 4.1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while FTOCU trades at $11.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas FTOCU's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to FTOCU's ROE of +0.07%. Regarding short-term risk, OACCU is less volatile compared to FTOCU. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check FTOCU's competition here
Tuscan Holdings Corp. (NASDAQ: THCBU)
OACCU vs THCBU Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, THCBU has a market cap of 3.9B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while THCBU trades at $12.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas THCBU's P/E ratio is -101.87. In terms of profitability, OACCU's ROE is +0.03%, compared to THCBU's ROE of +0.01%. Regarding short-term risk, OACCU is less volatile compared to THCBU. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check THCBU's competition here
Climate Change Crisis Real Impact I Acquisition Corporation (NYSE: CLII)
OACCU vs CLII Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, CLII has a market cap of 3.8B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while CLII trades at $14.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas CLII's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to CLII's ROE of -0.31%. Regarding short-term risk, OACCU is less volatile compared to CLII. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check CLII's competition here
GreenVision Acquisition Corp. (NASDAQ: GRNV)
OACCU vs GRNV Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, GRNV has a market cap of 3.8B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while GRNV trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas GRNV's P/E ratio is -59.68. In terms of profitability, OACCU's ROE is +0.03%, compared to GRNV's ROE of +0.04%. Regarding short-term risk, OACCU is less volatile compared to GRNV. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check GRNV's competition here
Forest Road Acquisition Corp. (NYSE: FRX)
OACCU vs FRX Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, FRX has a market cap of 3.7B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while FRX trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas FRX's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to FRX's ROE of +0.39%. Regarding short-term risk, OACCU is less volatile compared to FRX. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check FRX's competition here
Holicity Inc. (NASDAQ: HOLUU)
OACCU vs HOLUU Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, HOLUU has a market cap of 3.7B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while HOLUU trades at $13.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas HOLUU's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to HOLUU's ROE of -0.13%. Regarding short-term risk, OACCU is less volatile compared to HOLUU. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check HOLUU's competition here
Silver Spike Acquisition Corp. (NASDAQ: SSPK)
OACCU vs SSPK Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, SSPK has a market cap of 3.4B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while SSPK trades at $18.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas SSPK's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to SSPK's ROE of +0.04%. Regarding short-term risk, OACCU is less volatile compared to SSPK. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check SSPK's competition here
Falcon Capital Acquisition Corp. (NASDAQ: FCACU)
OACCU vs FCACU Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, FCACU has a market cap of 3.4B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while FCACU trades at $9.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas FCACU's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to FCACU's ROE of -0.00%. Regarding short-term risk, OACCU is less volatile compared to FCACU. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check FCACU's competition here
CF Acquisition Corp. VI (NASDAQ: CFVI)
OACCU vs CFVI Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, CFVI has a market cap of 3.4B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while CFVI trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas CFVI's P/E ratio is -18.55. In terms of profitability, OACCU's ROE is +0.03%, compared to CFVI's ROE of -0.47%. Regarding short-term risk, OACCU is less volatile compared to CFVI. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check CFVI's competition here
Holicity Inc. (NASDAQ: HOL)
OACCU vs HOL Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, HOL has a market cap of 3.3B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while HOL trades at $12.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas HOL's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to HOL's ROE of -0.13%. Regarding short-term risk, OACCU is less volatile compared to HOL. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check HOL's competition here
Tuscan Holdings Corp. (NASDAQ: THCB)
OACCU vs THCB Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, THCB has a market cap of 3.1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while THCB trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas THCB's P/E ratio is -81.30. In terms of profitability, OACCU's ROE is +0.03%, compared to THCB's ROE of +0.01%. Regarding short-term risk, OACCU is less volatile compared to THCB. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check THCB's competition here
Sustainable Opportunities Acquisition Corp. (NYSE: SOAC)
OACCU vs SOAC Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, SOAC has a market cap of 2.8B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while SOAC trades at $10.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas SOAC's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to SOAC's ROE of +0.53%. Regarding short-term risk, OACCU is less volatile compared to SOAC. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check SOAC's competition here
Decarbonization Plus Acquisition Corporation (NASDAQ: DCRBU)
OACCU vs DCRBU Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, DCRBU has a market cap of 2.8B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while DCRBU trades at $11.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas DCRBU's P/E ratio is -16.00. In terms of profitability, OACCU's ROE is +0.03%, compared to DCRBU's ROE of -0.84%. Regarding short-term risk, OACCU is less volatile compared to DCRBU. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check DCRBU's competition here
Ivanhoe Capital Acquisition Corp. (NYSE: IVAN)
OACCU vs IVAN Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, IVAN has a market cap of 2.7B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while IVAN trades at $7.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas IVAN's P/E ratio is -698.18. In terms of profitability, OACCU's ROE is +0.03%, compared to IVAN's ROE of -0.33%. Regarding short-term risk, OACCU is less volatile compared to IVAN. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check IVAN's competition here
Good Works Acquisition Corp. (NASDAQ: GWAC)
OACCU vs GWAC Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, GWAC has a market cap of 2.6B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while GWAC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas GWAC's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to GWAC's ROE of -0.59%. Regarding short-term risk, OACCU is less volatile compared to GWAC. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check GWAC's competition here
Landcadia Holdings III, Inc (NASDAQ: LCYAU)
OACCU vs LCYAU Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, LCYAU has a market cap of 2.6B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while LCYAU trades at $13.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas LCYAU's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to LCYAU's ROE of +0.04%. Regarding short-term risk, OACCU is more volatile compared to LCYAU. This indicates higher risk in terms of short-term price fluctuations for OACCU.Check LCYAU's competition here
Fifth Wall Acquisition Corp. I (NASDAQ: FWAA)
OACCU vs FWAA Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, FWAA has a market cap of 2.4B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while FWAA trades at $12.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas FWAA's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to FWAA's ROE of -0.09%. Regarding short-term risk, OACCU is less volatile compared to FWAA. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check FWAA's competition here
GS Acquisition Holdings Corp II (NYSE: GSAH)
OACCU vs GSAH Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, GSAH has a market cap of 2.4B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while GSAH trades at $10.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas GSAH's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to GSAH's ROE of +0.42%. Regarding short-term risk, OACCU is less volatile compared to GSAH. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check GSAH's competition here
Landcadia Holdings III, Inc (NASDAQ: LCY)
OACCU vs LCY Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, LCY has a market cap of 2.4B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while LCY trades at $12.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas LCY's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to LCY's ROE of +0.04%. Regarding short-term risk, OACCU is less volatile compared to LCY. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check LCY's competition here
Foresight Acquisition Corp. (NASDAQ: FORE)
OACCU vs FORE Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, FORE has a market cap of 2.3B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while FORE trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas FORE's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to FORE's ROE of +3.90%. Regarding short-term risk, OACCU is less volatile compared to FORE. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check FORE's competition here
Revolution Acceleration Acquisition Corp (NASDAQ: RAAC)
OACCU vs RAAC Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, RAAC has a market cap of 2.2B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while RAAC trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas RAAC's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to RAAC's ROE of +0.00%. Regarding short-term risk, OACCU is less volatile compared to RAAC. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check RAAC's competition here
Supernova Partners Acquisition Company, Inc. (NYSE: SPNV)
OACCU vs SPNV Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, SPNV has a market cap of 2.2B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while SPNV trades at $8.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas SPNV's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to SPNV's ROE of -0.99%. Regarding short-term risk, OACCU is less volatile compared to SPNV. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check SPNV's competition here
Social Capital Suvretta Holdings Corp. III (NASDAQ: DNAC)
OACCU vs DNAC Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, DNAC has a market cap of 2.2B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while DNAC trades at $9.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas DNAC's P/E ratio is -37.72. In terms of profitability, OACCU's ROE is +0.03%, compared to DNAC's ROE of -0.36%. Regarding short-term risk, OACCU is less volatile compared to DNAC. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check DNAC's competition here
Fortress Value Acquisition Corp. II (NYSE: FAII)
OACCU vs FAII Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, FAII has a market cap of 2.1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while FAII trades at $10.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas FAII's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to FAII's ROE of -0.32%. Regarding short-term risk, OACCU is less volatile compared to FAII. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check FAII's competition here
dMY Technology Group, Inc. III (NYSE: DMYI)
OACCU vs DMYI Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, DMYI has a market cap of 2.1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while DMYI trades at $10.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas DMYI's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to DMYI's ROE of -0.16%. Regarding short-term risk, OACCU is less volatile compared to DMYI. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check DMYI's competition here
Live Oak Acquisition Corp. II (NYSE: LOKB)
OACCU vs LOKB Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, LOKB has a market cap of 2.1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while LOKB trades at $13.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas LOKB's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to LOKB's ROE of -0.62%. Regarding short-term risk, OACCU is less volatile compared to LOKB. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check LOKB's competition here
Star Peak Corp II (NYSE: STPC)
OACCU vs STPC Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, STPC has a market cap of 2B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while STPC trades at $9.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas STPC's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to STPC's ROE of -0.29%. Regarding short-term risk, OACCU is less volatile compared to STPC. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check STPC's competition here
Mudrick Capital Acquisition Corporation II (NASDAQ: MUDS)
OACCU vs MUDS Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, MUDS has a market cap of 2B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while MUDS trades at $10.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas MUDS's P/E ratio is 3.39. In terms of profitability, OACCU's ROE is +0.03%, compared to MUDS's ROE of -0.01%. Regarding short-term risk, OACCU is more volatile compared to MUDS. This indicates higher risk in terms of short-term price fluctuations for OACCU.Check MUDS's competition here
Mudrick Capital Acquisition Corporation II (NASDAQ: MUDSU)
OACCU vs MUDSU Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, MUDSU has a market cap of 2B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while MUDSU trades at $10.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas MUDSU's P/E ratio is -1125.56. In terms of profitability, OACCU's ROE is +0.03%, compared to MUDSU's ROE of -0.01%. Regarding short-term risk, OACCU is more volatile compared to MUDSU. This indicates higher risk in terms of short-term price fluctuations for OACCU.Check MUDSU's competition here
Apex Treasury Corporation (NASDAQ: APXTW)
OACCU vs APXTW Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, APXTW has a market cap of 2B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while APXTW trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas APXTW's P/E ratio is 2.21. In terms of profitability, OACCU's ROE is +0.03%, compared to APXTW's ROE of +0.16%. Regarding short-term risk, OACCU is less volatile compared to APXTW. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check APXTW's competition here
Tiga Acquisition Corp. (NYSE: TINV)
OACCU vs TINV Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, TINV has a market cap of 2B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while TINV trades at $11.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas TINV's P/E ratio is 30.61. In terms of profitability, OACCU's ROE is +0.03%, compared to TINV's ROE of +3.57%. Regarding short-term risk, OACCU is less volatile compared to TINV. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check TINV's competition here
Apex Treasury Corporation (NASDAQ: APXTU)
OACCU vs APXTU Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, APXTU has a market cap of 1.9B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while APXTU trades at $10.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas APXTU's P/E ratio is 75.63. In terms of profitability, OACCU's ROE is +0.03%, compared to APXTU's ROE of +0.16%. Regarding short-term risk, OACCU is more volatile compared to APXTU. This indicates higher risk in terms of short-term price fluctuations for OACCU.Check APXTU's competition here
Apex Treasury Corporation Class A (NASDAQ: APXT)
OACCU vs APXT Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, APXT has a market cap of 1.9B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while APXT trades at $10.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas APXT's P/E ratio is 74.59. In terms of profitability, OACCU's ROE is +0.03%, compared to APXT's ROE of +0.16%. Regarding short-term risk, OACCU is more volatile compared to APXT. This indicates higher risk in terms of short-term price fluctuations for OACCU.Check APXT's competition here
Digital World Acquisition Corp. (NASDAQ: DWAC)
OACCU vs DWAC Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, DWAC has a market cap of 1.9B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while DWAC trades at $49.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas DWAC's P/E ratio is -73.46. In terms of profitability, OACCU's ROE is +0.03%, compared to DWAC's ROE of -0.84%. Regarding short-term risk, OACCU is less volatile compared to DWAC. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check DWAC's competition here
Digital World Acquisition Corp. (NASDAQ: DWACU)
OACCU vs DWACU Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, DWACU has a market cap of 1.9B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while DWACU trades at $61.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas DWACU's P/E ratio is -451.10. In terms of profitability, OACCU's ROE is +0.03%, compared to DWACU's ROE of -0.84%. Regarding short-term risk, OACCU is less volatile compared to DWACU. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check DWACU's competition here
Athena Technology Acquisition Corp. (NYSE: ATHN)
OACCU vs ATHN Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, ATHN has a market cap of 1.8B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while ATHN trades at $9.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas ATHN's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to ATHN's ROE of +2.24%. Regarding short-term risk, OACCU is less volatile compared to ATHN. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check ATHN's competition here
Gores Metropoulos II, Inc. (NASDAQ: GMII)
OACCU vs GMII Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, GMII has a market cap of 1.8B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while GMII trades at $8.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas GMII's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to GMII's ROE of +1.03%. Regarding short-term risk, OACCU is less volatile compared to GMII. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check GMII's competition here
Churchill Capital Corp XI Warrants (NASDAQ: CCXIW)
OACCU vs CCXIW Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, CCXIW has a market cap of 1.8B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while CCXIW trades at $4.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas CCXIW's P/E ratio is -1.95. In terms of profitability, OACCU's ROE is +0.03%, compared to CCXIW's ROE of N/A. Regarding short-term risk, OACCU is less volatile compared to CCXIW. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check CCXIW's competition here
Motive Capital Corp. (NYSE: MOTV)
OACCU vs MOTV Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, MOTV has a market cap of 1.7B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while MOTV trades at $10.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas MOTV's P/E ratio is 55.86. In terms of profitability, OACCU's ROE is +0.03%, compared to MOTV's ROE of -0.15%. Regarding short-term risk, OACCU is less volatile compared to MOTV. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check MOTV's competition here
CBRE Acquisition Holdings, Inc. (NYSE: CBAH)
OACCU vs CBAH Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, CBAH has a market cap of 1.7B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while CBAH trades at $10.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas CBAH's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to CBAH's ROE of +0.04%. Regarding short-term risk, OACCU is less volatile compared to CBAH. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check CBAH's competition here
GX Acquisition Corp. (NASDAQ: GXGXU)
OACCU vs GXGXU Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, GXGXU has a market cap of 1.7B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while GXGXU trades at $11.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas GXGXU's P/E ratio is -23.73. In terms of profitability, OACCU's ROE is +0.03%, compared to GXGXU's ROE of -0.03%. Regarding short-term risk, OACCU is less volatile compared to GXGXU. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check GXGXU's competition here
One (NYSE: AONE)
OACCU vs AONE Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, AONE has a market cap of 1.7B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while AONE trades at $8.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas AONE's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to AONE's ROE of -17.11%. Regarding short-term risk, OACCU is less volatile compared to AONE. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check AONE's competition here
Tortoise Acquisition Corp. II (NYSE: SNPR)
OACCU vs SNPR Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, SNPR has a market cap of 1.6B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while SNPR trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas SNPR's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to SNPR's ROE of +0.00%. Regarding short-term risk, OACCU is less volatile compared to SNPR. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check SNPR's competition here
Jaws Spitfire Acquisition Corporation (NYSE: SPFR)
OACCU vs SPFR Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, SPFR has a market cap of 1.6B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while SPFR trades at $8.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas SPFR's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to SPFR's ROE of -4.57%. Regarding short-term risk, OACCU is less volatile compared to SPFR. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check SPFR's competition here
D8 Holdings Corp. (NYSE: DEH)
OACCU vs DEH Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, DEH has a market cap of 1.6B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while DEH trades at $11.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas DEH's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to DEH's ROE of -3.33%. Regarding short-term risk, OACCU is less volatile compared to DEH. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check DEH's competition here
Rotor Acquisition Corp. (NYSE: ROT)
OACCU vs ROT Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, ROT has a market cap of 1.6B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while ROT trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas ROT's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to ROT's ROE of -0.45%. Regarding short-term risk, OACCU is less volatile compared to ROT. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check ROT's competition here
NextGen Acquisition Corporation (NASDAQ: NGAC)
OACCU vs NGAC Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, NGAC has a market cap of 1.5B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while NGAC trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas NGAC's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to NGAC's ROE of -0.80%. Regarding short-term risk, OACCU is less volatile compared to NGAC. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check NGAC's competition here
Celularity Inc. (NASDAQ: GXGX)
OACCU vs GXGX Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, GXGX has a market cap of 1.5B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while GXGX trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas GXGX's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to GXGX's ROE of +3.07%. Regarding short-term risk, OACCU is less volatile compared to GXGX. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check GXGX's competition here
Hudson Executive Investment Corp. (NASDAQ: HECCU)
OACCU vs HECCU Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, HECCU has a market cap of 1.4B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while HECCU trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas HECCU's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to HECCU's ROE of -0.10%. Regarding short-term risk, OACCU is less volatile compared to HECCU. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check HECCU's competition here
Altimar Acquisition Corp. II (NYSE: ATMR)
OACCU vs ATMR Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, ATMR has a market cap of 1.4B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while ATMR trades at $10.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas ATMR's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to ATMR's ROE of +0.44%. Regarding short-term risk, OACCU is less volatile compared to ATMR. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check ATMR's competition here
Osprey Technology Acquisition Corp. (NYSE: SFTW)
OACCU vs SFTW Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, SFTW has a market cap of 1.4B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while SFTW trades at $11.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas SFTW's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to SFTW's ROE of -0.56%. Regarding short-term risk, OACCU is less volatile compared to SFTW. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check SFTW's competition here
890 5th Avenue Partners, Inc. (NASDAQ: ENFA)
OACCU vs ENFA Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, ENFA has a market cap of 1.3B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while ENFA trades at $9.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas ENFA's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to ENFA's ROE of -1.15%. Regarding short-term risk, OACCU is less volatile compared to ENFA. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check ENFA's competition here
Environmental Impact Acquisition Corp. (NASDAQ: ENVI)
OACCU vs ENVI Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, ENVI has a market cap of 1.3B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while ENVI trades at $8.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas ENVI's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to ENVI's ROE of +0.00%. Regarding short-term risk, OACCU is less volatile compared to ENVI. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check ENVI's competition here
ArcLight Clean Transition Corp. II (NASDAQ: ACTD)
OACCU vs ACTD Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, ACTD has a market cap of 1.3B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while ACTD trades at $7.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas ACTD's P/E ratio is -25.50. In terms of profitability, OACCU's ROE is +0.03%, compared to ACTD's ROE of -0.00%. Regarding short-term risk, OACCU is less volatile compared to ACTD. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check ACTD's competition here
Vickers Vantage Corp. I (NASDAQ: VCKA)
OACCU vs VCKA Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, VCKA has a market cap of 1.3B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while VCKA trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas VCKA's P/E ratio is 100.11. In terms of profitability, OACCU's ROE is +0.03%, compared to VCKA's ROE of +1.87%. Regarding short-term risk, OACCU is less volatile compared to VCKA. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check VCKA's competition here
Thimble Point Acquisition Corp. (NASDAQ: THMA)
OACCU vs THMA Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, THMA has a market cap of 1.3B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while THMA trades at $9.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas THMA's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to THMA's ROE of +0.00%. Regarding short-term risk, OACCU is less volatile compared to THMA. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check THMA's competition here
L&F Acquisition Corp. (NYSE: LNFA)
OACCU vs LNFA Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, LNFA has a market cap of 1.3B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while LNFA trades at $10.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas LNFA's P/E ratio is 21.06. In terms of profitability, OACCU's ROE is +0.03%, compared to LNFA's ROE of +0.09%. Regarding short-term risk, OACCU is less volatile compared to LNFA. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check LNFA's competition here
Fintech Acquisition Corp. IV (NASDAQ: FTIVU)
OACCU vs FTIVU Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, FTIVU has a market cap of 1.3B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while FTIVU trades at $14.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas FTIVU's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to FTIVU's ROE of -0.14%. Regarding short-term risk, OACCU is less volatile compared to FTIVU. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check FTIVU's competition here
ACON S2 Acquisition Corp. (NASDAQ: STWO)
OACCU vs STWO Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, STWO has a market cap of 1.3B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while STWO trades at $8.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas STWO's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to STWO's ROE of +4.68%. Regarding short-term risk, OACCU is less volatile compared to STWO. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check STWO's competition here
Haymaker Acquisition Corp. III (NASDAQ: HYACU)
OACCU vs HYACU Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, HYACU has a market cap of 1.2B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while HYACU trades at $10.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas HYACU's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to HYACU's ROE of -0.11%. Regarding short-term risk, OACCU is more volatile compared to HYACU. This indicates higher risk in terms of short-term price fluctuations for OACCU.Check HYACU's competition here
Fintech Acquisition Corp. IV (NASDAQ: FTIV)
OACCU vs FTIV Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, FTIV has a market cap of 1.2B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while FTIV trades at $13.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas FTIV's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to FTIV's ROE of -0.14%. Regarding short-term risk, OACCU is less volatile compared to FTIV. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check FTIV's competition here
Alpha Healthcare Acquisition Corp. (NASDAQ: AHAC)
OACCU vs AHAC Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, AHAC has a market cap of 1.1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while AHAC trades at $10.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas AHAC's P/E ratio is -72.11. In terms of profitability, OACCU's ROE is +0.03%, compared to AHAC's ROE of -5.42%. Regarding short-term risk, OACCU is less volatile compared to AHAC. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check AHAC's competition here
Amplitude Healthcare Acquisition Corporation (NASDAQ: AMHC)
OACCU vs AMHC Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, AMHC has a market cap of 1.1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while AMHC trades at $10.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas AMHC's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to AMHC's ROE of +0.00%. Regarding short-term risk, OACCU is less volatile compared to AMHC. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check AMHC's competition here
FTAC Hera Acquisition Corp. (NASDAQ: HERAW)
OACCU vs HERAW Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, HERAW has a market cap of 1.1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while HERAW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas HERAW's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to HERAW's ROE of +0.01%. Regarding short-term risk, OACCU is less volatile compared to HERAW. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check HERAW's competition here
FTAC Hera Acquisition Corp. (NASDAQ: HERA)
OACCU vs HERA Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, HERA has a market cap of 1.1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while HERA trades at $10.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas HERA's P/E ratio is 46.32. In terms of profitability, OACCU's ROE is +0.03%, compared to HERA's ROE of +0.01%. Regarding short-term risk, OACCU is more volatile compared to HERA. This indicates higher risk in terms of short-term price fluctuations for OACCU.Check HERA's competition here
FG New America Acquisition Corp. (NYSE: FGNA)
OACCU vs FGNA Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, FGNA has a market cap of 1.1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while FGNA trades at $9.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas FGNA's P/E ratio is -4.35. In terms of profitability, OACCU's ROE is +0.03%, compared to FGNA's ROE of +0.46%. Regarding short-term risk, OACCU is less volatile compared to FGNA. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check FGNA's competition here
Social Capital Suvretta Holdings Corp. I (NASDAQ: DNAA)
OACCU vs DNAA Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, DNAA has a market cap of 1.1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while DNAA trades at $14.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas DNAA's P/E ratio is -54.53. In terms of profitability, OACCU's ROE is +0.03%, compared to DNAA's ROE of +0.00%. Regarding short-term risk, OACCU is less volatile compared to DNAA. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check DNAA's competition here
Therapeutics Acquisition Corp. (NASDAQ: RACA)
OACCU vs RACA Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, RACA has a market cap of 1.1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while RACA trades at $10.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas RACA's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to RACA's ROE of +0.00%. Regarding short-term risk, OACCU is less volatile compared to RACA. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check RACA's competition here
Trebia Acquisition Corp. (NYSE: TREB)
OACCU vs TREB Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, TREB has a market cap of 1.1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while TREB trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas TREB's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to TREB's ROE of -12.26%. Regarding short-term risk, OACCU is less volatile compared to TREB. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check TREB's competition here
TPG Pace Tech Opportunities Corp. (NYSE: PACE)
OACCU vs PACE Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, PACE has a market cap of 1.1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while PACE trades at $11.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas PACE's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to PACE's ROE of -1.52%. Regarding short-term risk, OACCU is less volatile compared to PACE. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check PACE's competition here
FTAC Hera Acquisition Corp. (NASDAQ: HERAU)
OACCU vs HERAU Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, HERAU has a market cap of 1.1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while HERAU trades at $10.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas HERAU's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to HERAU's ROE of +0.01%. Regarding short-term risk, OACCU is more volatile compared to HERAU. This indicates higher risk in terms of short-term price fluctuations for OACCU.Check HERAU's competition here
LifeSci Acquisition II Corp. (NASDAQ: LSAQ)
OACCU vs LSAQ Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, LSAQ has a market cap of 1.1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while LSAQ trades at $9.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas LSAQ's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to LSAQ's ROE of N/A. Regarding short-term risk, OACCU is less volatile compared to LSAQ. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check LSAQ's competition here
Stable Road Acquisition Corp. (NASDAQ: SRAC)
OACCU vs SRAC Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, SRAC has a market cap of 1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while SRAC trades at $10.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas SRAC's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to SRAC's ROE of -0.90%. Regarding short-term risk, OACCU is less volatile compared to SRAC. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check SRAC's competition here
FTAC Parnassus Acquisition Corp. (NASDAQ: FTPAW)
OACCU vs FTPAW Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, FTPAW has a market cap of 1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while FTPAW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas FTPAW's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to FTPAW's ROE of -0.00%. Regarding short-term risk, OACCU is more volatile compared to FTPAW. This indicates higher risk in terms of short-term price fluctuations for OACCU.Check FTPAW's competition here
Sandbridge Acquisition Corporation (NYSE: SBG)
OACCU vs SBG Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, SBG has a market cap of 1B. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while SBG trades at $8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas SBG's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to SBG's ROE of -0.51%. Regarding short-term risk, OACCU is less volatile compared to SBG. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check SBG's competition here
Churchill Capital Corp VII (NYSE: CVII-WT)
OACCU vs CVII-WT Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, CVII-WT has a market cap of 977.9M. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while CVII-WT trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas CVII-WT's P/E ratio is N/A. In terms of profitability, OACCU's ROE is +0.03%, compared to CVII-WT's ROE of +0.02%. Regarding short-term risk, OACCU is more volatile compared to CVII-WT. This indicates higher risk in terms of short-term price fluctuations for OACCU.Check CVII-WT's competition here
Churchill Capital Corp VII (NYSE: CVII-UN)
OACCU vs CVII-UN Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, CVII-UN has a market cap of 958.8M. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while CVII-UN trades at $10.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas CVII-UN's P/E ratio is 64.65. In terms of profitability, OACCU's ROE is +0.03%, compared to CVII-UN's ROE of +0.02%. Regarding short-term risk, OACCU is less volatile compared to CVII-UN. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check CVII-UN's competition here
Bleichroeder Acquisition Corp. II (NASDAQ: BBCQW)
OACCU vs BBCQW Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, BBCQW has a market cap of 954.5M. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while BBCQW trades at $1.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas BBCQW's P/E ratio is -25.90. In terms of profitability, OACCU's ROE is +0.03%, compared to BBCQW's ROE of N/A. Regarding short-term risk, OACCU is less volatile compared to BBCQW. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check BBCQW's competition here
B. Riley Principal 150 Merger Corp. (NASDAQ: BRPM)
OACCU vs BRPM Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, BRPM has a market cap of 944M. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while BRPM trades at $13.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas BRPM's P/E ratio is -72.74. In terms of profitability, OACCU's ROE is +0.03%, compared to BRPM's ROE of +4.56%. Regarding short-term risk, OACCU is less volatile compared to BRPM. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check BRPM's competition here
Crescent Acquisition Corp. (NASDAQ: CRSAU)
OACCU vs CRSAU Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, CRSAU has a market cap of 937.8M. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while CRSAU trades at $10.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas CRSAU's P/E ratio is -27.21. In terms of profitability, OACCU's ROE is +0.03%, compared to CRSAU's ROE of -0.34%. Regarding short-term risk, OACCU is less volatile compared to CRSAU. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check CRSAU's competition here
Churchill Capital Corp VII (NYSE: CVII)
OACCU vs CVII Comparison October 2026
Oaktree Acquisition Corp. III Life Sciences Unit (NASDAQ: OACCU) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OACCU stands at 259.7M. In comparison, CVII has a market cap of 914.7M. Regarding current trading prices, OACCU is priced at $10.86 on the NASDAQ, while CVII trades at $9.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OACCU currently has a P/E ratio of 39.52, whereas CVII's P/E ratio is 999.00. In terms of profitability, OACCU's ROE is +0.03%, compared to CVII's ROE of +0.02%. Regarding short-term risk, OACCU is less volatile compared to CVII. This indicates lower risk in terms of short-term price fluctuations for OACCU.Check CVII's competition here